Mikhail Kosiborod

Also affiliated with Saint Luke's Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.861Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Diabetes Care Among Older Adults Enrolled in Medicare Advantage Versus Traditional Medicare Fee-For-Service Plans: The Diabetes Collaborative Registry

Diabetes Care(2022)10.2337/dc21-1178

Top 23%

0.861DataRank

Top 23%17 citations

Yuanyuan Tang, José F. Figueroa, Terrence M. A. Litam, Fengming Tang, Philip G. Jones +7 more

Papers

Driven by 67 papers — median percentile 77. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Nature Medicine(2023)10.1038/s41591-023-02526-x

N/A

5.5DataRank · unranked

193 citations

Dalane W. Kitzman, Melanie J. Davies, Søren Rasmussen, Eric Barros, Javed Butler +23 more

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

The Lancet(2024)10.1016/s0140-6736(24)00469-0

N/A

5.3DataRank · unranked

335 citations

Sanjiv J. Shah, Mark C. Petrie, Barry A. Borlaug, Steen Z. Abildstrøm, Melanie J. Davies +27 more

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.008

N/A

5.0DataRank · unranked

142 citations

Pardeep S. Jhund, Brian Claggett, Pooja Dewan, Lars Køber, Mikhail Kosiborod +11 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2022)10.1161/circulationaha.122.061754

N/A

4.2DataRank · unranked

152 citations

Pardeep S. Jhund, Jan Bělohlávek, Rudolf A. de Boer, Chern‐En Chiang, Akshay S. Desai +22 more

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3750

N/A

2.9DataRank · unranked

67 citations

Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi +12 more

Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.09.811

N/A

2.7DataRank · unranked

82 citations

Steen Z. Abildstrøm, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie +19 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Circulation(2021)10.1161/circulationaha.121.053659

N/A

2.5DataRank · unranked

60 citations

Piotr Ponikowski, Kieran F. Docherty, Samvel B. Gasparyan, Michael Böhm, Chern‐En Chiang +16 more

Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

Circulation(2023)10.1161/circulationaha.123.067505

N/A

2.5DataRank · unranked

96 citations

Subodh Verma, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Thomas Jensen +10 more

Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.04.038

N/A

2.0DataRank · unranked

48 citations

Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman +9 more

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine(2022)10.1038/s41591-022-02102-9

N/A

1.7DataRank · unranked

67 citations

James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan +19 more

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

European Heart Journal(2023)10.1093/eurheartj/ehad283

N/A

1.6DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Orly Vardeny, Akshay S. Desai, Pardeep S. Jhund +15 more

Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.08.023

N/A

1.6DataRank · unranked

37 citations

Javed Butler, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie +8 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

1.5DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2022)10.1016/j.jchf.2022.08.007

N/A

1.5DataRank · unranked

50 citations

Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer +13 more

Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.009

N/A

1.4DataRank · unranked

29 citations

Pooja Dewan, Ersilia M. DeFilippis, Tor Biering‐Sørensen, Kieran F. Docherty, Pardeep S. Jhund +13 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials

Circulation Heart Failure(2023)10.1161/circheartfailure.122.009837

N/A

1.3DataRank · unranked

62 citations

Sheryl L. Windsor, Kensey Gosch, Barry A. Borlaug, Mansoor Husain, Silvio E. Inzucchi +12 more

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.066506

N/A

1.3DataRank · unranked

36 citations

Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Kieran F. Docherty, Akshay S. Desai +13 more

Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00308-4

N/A

1.2DataRank · unranked

41 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer +14 more

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007879

N/A

1.1DataRank · unranked

27 citations

Pooja Dewan, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +9 more

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Circulation(2022)10.1161/circulationaha.122.062769

N/A

1.1DataRank · unranked

35 citations

C. David Mazer, Pankaj Puar, Hwee Teoh, Chao‐Hung Wang, Tamique Mason +29 more

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.4664

N/A

1.0DataRank · unranked

38 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Orly Vardeny +17 more

Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials

European Journal of Heart Failure(2023)10.1002/ejhf.2909

N/A

1.0DataRank · unranked

22 citations

Mikhail Kosiborod, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Ian J. Kulac +13 more

Relationship of Dapagliflozin With Serum Sodium

JACC Heart Failure(2022)10.1016/j.jchf.2022.01.019

N/A

0.999DataRank · unranked

31 citations

Kieran F. Docherty, Pardeep S. Jhund, Mark C. Petrie, Silvio E. Inzucchi, Lars Køber +12 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Heart Failure, Chronic Obstructive Pulmonary Disease and Efficacy and Safety of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from DELIVER

European Journal of Heart Failure(2023)10.1002/ejhf.3000

N/A

0.889DataRank · unranked

26 citations

Henri Lu, Toru Kondo, Erasmus Bachus, Rudolf A. de Boer, Silvio E. Inzucchi +8 more

Diabetes Care Among Older Adults Enrolled in Medicare Advantage Versus Traditional Medicare Fee-For-Service Plans: The Diabetes Collaborative Registry

Diabetes Care(2022)10.2337/dc21-1178

Top 23%

0.861DataRank

Top 23%17 citations

Yuanyuan Tang, José F. Figueroa, Terrence M. A. Litam, Fengming Tang, Philip G. Jones +7 more

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.065254

N/A

0.805DataRank · unranked

21 citations

Muthiah Vaduganathan, Senthil Selvaraj, Brian Claggett, Zi Michael Miao, Akshay S. Desai +13 more

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

Circulation Heart Failure(2024)10.1161/circheartfailure.124.011980

N/A

0.751DataRank · unranked

29 citations

Shachi Patel, Andrew J. Sauer, Robert W. McGarrah, Philip G. Jones, Lydia Coulter Kwee +19 more

Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00362-0

N/A

0.700DataRank · unranked

31 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Silvio E. Inzucchi +17 more

Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial

European Journal of Heart Failure(2023)10.1002/ejhf.3043

N/A

0.691DataRank · unranked

16 citations

Mikhail Kosiborod, Brian Claggett, Zi Michael Miao, Muthiah Vaduganathan, Carolyn S.P. Lam +19 more

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.1342

N/A

0.671DataRank · unranked

13 citations

Alvin Chandra, Mikhail Kosiborod, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund +17 more

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

JACC Heart Failure(2022)10.1016/j.jchf.2021.09.002

N/A

0.614DataRank · unranked

13 citations

Joanne Simpson, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +10 more

Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00304-8

N/A

0.613DataRank · unranked

20 citations

Peter van der Meer, Subodh Verma, Shachi Patel, Khaja Chinnakondepalli, Barry A Borlaug +11 more

Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2024)10.1016/j.jchf.2024.02.018

N/A

0.567DataRank · unranked

16 citations

Shachi Patel, Andrew J. Sauer, Robert W. McGarrah, Philip G. Jones, Lydia Coulter Kwee +10 more

Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00218-3

N/A

0.449DataRank · unranked

13 citations

Sheryl L. Windsor, Orly Vardeny, Jeffrey S. Berger, Harmony R Reynolds, Stavroula Boumakis +75 more

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2023)10.1161/circulationaha.122.062918

N/A

0.405DataRank · unranked

7 citations

Karola Jering, C. Jan Willem Borleffs, Rudolf A. de Boer, Brian Claggett, Akshay S. Desai +15 more

Semaglutide and Exercise Function in Obesity-Related HFpEF

JACC Heart Failure(2025)10.1016/j.jchf.2025.102660

N/A

0.328DataRank · unranked

5 citations

Dalane W. Kitzman, Shachi Patel, Khaja Chinnakondepalli, Javed Butler, Melanie J. Davies +9 more

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

Cardiovascular Diabetology(2025)10.1186/s12933-025-02875-6

N/A

0DataRank · unranked

0 citations

Remo H.M. Furtado, Russell Esterline, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch +18 more

Regional differences in the management of cardiovascular risk factors among adults with diabetes: An evaluation of the Diabetes Collaborative Registry

Journal of Diabetes and its Complications(2020)10.1016/j.jdiacomp.2020.107591

N/A

0DataRank · unranked

4 citations

Nathan D. Wong, Jane E.B. Reusch, Suzanne V. Arnold, Mikhail Kosiborod, Yuanyuan Tang +3 more

Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes

JACC Heart Failure(2021)10.1016/j.jchf.2020.10.013

N/A

0DataRank · unranked

134 citations

Muthiah Vaduganathan, Kershaw V. Patel, Colby Ayers, Christie M. Ballantyne, Mikhail Kosiborod +8 more

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial

European Journal of Heart Failure(2021)10.1002/ejhf.2137

N/A

0DataRank · unranked

103 citations

Piotr Ponikowski, Afshin Salsali, Christiane E. Angermann, Jan Biegus, Jon Blatchford +10 more

SGLT-2 Inhibitors in Heart Failure

Journal of the American College of Cardiology(2021)10.1016/j.jacc.2021.02.005

N/A

0DataRank · unranked

6 citations

Muthiah Vaduganathan, Mikhail Kosiborod

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

The Lancet(2022)10.1016/s0140-6736(22)01429-5

N/A

0DataRank · unranked

930 citations

Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez +9 more

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update

Endocrine Practice(2022)10.1016/j.eprac.2022.08.002

N/A

0DataRank · unranked

476 citations

Guillermo E. Umpierrez, Sarah Reddy, Janet B. McGill, Sarah L. Berga, Michael A. Bush +24 more

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER

BMC Endocrine Disorders(2022)10.1186/s12902-022-01026-2

N/A

0DataRank · unranked

81 citations

Fengming Tang, Andrew Cooper, Hungta Chen, Marília Brito Gomes, Wolfgang Rathmann +6 more

Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan

European Journal of Heart Failure(2022)10.1002/ejhf.2722

N/A

0DataRank · unranked

34 citations

Jawad H. Butt, Toru Kondo, Karola Jering, Kieran F. Docherty, Pardeep S. Jhund +16 more

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19

Diabetes Care(2022)10.2337/dc22-0357

N/A

0DataRank · unranked

23 citations

Yue Ruan, Jim Davies, Benjamin C. T. Field, Sophie Harris, Mikhail Kosiborod +83 more

Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study

Indian Heart Journal(2022)10.1016/j.ihj.2022.07.008

N/A

0DataRank · unranked

2 citations

Hungta Chen, Fengming Tang, Paul Chan, Andrew Cooper, Marília Brito Gomes +11 more

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

Circulation(2023)10.1161/cir.0000000000001184

N/A

0DataRank · unranked

1755 citations

Janani Rangaswami, Sheryl L. Chow, Ian J. Neeland, Katherine R. Tuttle, Sadiya S. Khan +24 more

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

Cell Metabolism(2023)10.1016/j.cmet.2023.02.006

N/A

0DataRank · unranked

94 citations

Zhen Guo, Carla Valenzuela Ripoll, Ahmed Diab, Antonino Picataggi, David R. Rawnsley +16 more

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

JACC Heart Failure(2023)10.1016/j.jchf.2023.05.026

N/A

0DataRank · unranked

46 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire +17 more

The Win Ratio Method in Heart Failure Trials: Lessons Learnt from EMPULSE

European Journal of Heart Failure(2023)10.1002/ejhf.2853

N/A

0DataRank · unranked

44 citations

João Pedro Ferreira, Timothy Collier, Christiane E. Angermann, Jan Biegus, Sean P. Collins +11 more

Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

Progress in Cardiovascular Diseases(2023)10.1016/j.pcad.2023.05.002

N/A

0DataRank · unranked

22 citations

Jingtong Huang, Ambarish Pandey, Ibrahim A. Hashim, David Kerr, Rodica Pop‐Busui +30 more

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.14428

N/A

0DataRank · unranked

17 citations

Matthew D. Neal, Lucy Z. Kornblith, Michelle N. Gong, Harmony R. Reynolds, Mary Cushman +72 more

Association Between Change in Ambulatory Pulmonary Artery Pressures and Natriuretic Peptides in Patients with Heart Failure: Results From the EMBRACE-HF Trial

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.05.009

N/A

0DataRank · unranked

8 citations

Dan Nguyen, John A. Spertus, Kensey Gosch, Fengming Tang, Sheryl L. Windsor +5 more

GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2024.10.448

N/A

0DataRank · unranked

23 citations

Ashish Kumar, Ammar Bhatti, Sourbha S. Dani, Sadeer Al‐Kindi, Khurram Nasir +18 more

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263

N/A

0DataRank · unranked

14 citations

Toru Kondo, Atefeh Talebi, Pardeep S. Jhund, Kieran F. Docherty, Brian Claggett +15 more

Geographical Variation in Patient Characteristics and Outcomes in Heart Failure with Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3352

N/A

0DataRank · unranked

12 citations

Toru Kondo, Pardeep S. Jhund, Marco A. Alcocer‐Gamba, C. Jan Willem Borleffs, Chern‐En Chiang +17 more

Dapagliflozin in Patients with Heart Failure and Previous Myocardial Infarction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER

European Journal of Heart Failure(2024)10.1002/ejhf.3184

N/A

0DataRank · unranked

11 citations

Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Alberto Foà, Akshay S. Desai +17 more

Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00219-5

N/A

0DataRank · unranked

11 citations

Peter J. Godolphin, David J. Fisher, Peter Horby, Mikhail Kosiborod, Judith S. Hochman +18 more

Gamified Behavioral Science Intervention to Enhance Trial Enrollment

JACC Heart Failure(2024)10.1016/j.jchf.2024.05.002

N/A

0DataRank · unranked

1 citations

Safia Chatur, Brian Claggett, James Lay‐Flurrie, Prabhakar Viswanathan, Orly Vardeny +5 more

Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans

JACC Advances(2025)10.1016/j.jacadv.2025.101839

N/A

0DataRank · unranked

4 citations

Aynaz Lotfinaghsh, Zhen Guo, Tripti Kumari, Kana N. Miyata, Alireza Sargazi +27 more

Survodutide for the Treatment of Obesity

JACC Heart Failure(2025)10.1016/j.jchf.2025.102780

N/A

0DataRank · unranked

1 citations

Lee M. Kaplan, Carel W. le Roux, Sean Wharton, Svenja Burger, Samina Ajaz Hussain +6 more

Mikhail Kosiborod

Indexed papers

Top data-sharing exemplar

Papers